Christopher Hite Net Worth & Insider Trades
Christopher Hite - EVP & Vice Chairman, Royalty Pharma Plc
What is Christopher Hite's Net Worth?
The current estimated net worth of Royalty Pharma Plc's EVP & Vice Chairman, Christopher Hite, is estimated to be about $2.11M . Christopher Hite owns about 0 unit of Royalty Pharma Plc common stock. In the last year at Royalty Pharma Plc, Christopher Hite has sold an estimated value of $0 worth.
What is Christopher Hite's Past Insider Trading?
Christopher Hite's largest purchase order was 70,000 units , worth over $1.96M on June 23, 2020. In total, Christopher Hite has made about 2 transactions over a year of their time at Royalty Pharma Plc. Christopher Hite usually trades in June and March, with the busiest year in 2021 and 2020. The most recent transaction was a purchase order of 0 unit , worth over $0 on March 25, 2021.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Christopher Hite
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Christopher Hite's Salary in 2020?
The vast majority of their compensation came in the form of other earnings, plans or compensations of $3,644,711 , and other compensation of $367,788 .
What is Christopher Hite's' Mailing Address?
- Mailing address is C/o Acceleron Pharma Inc. 128 Sidney Street Cambridge MA 02139 MA
Royalty Pharma Plc Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|
| Pablo Legorreta Pablo Legorreta | 2020 | $55,674,558 | $55,674,558 | $55,674,558 | $55,674,558 |
| Pablo Legorreta Pablo Legorreta | 2019 | $28,545,792 | $28,545,792 | $28,545,792 | $28,545,792 |
| Terrance Coyne Terrance Coyne | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| Terrance Coyne Terrance Coyne | 2019 | $1,925,625 | $1,925,625 | - | $1,925,625 |
| Christopher Hite | 2020 | $3,644,711 | $3,644,711 | $367,788 | $3,644,711 |
| Christopher Hite | 2019 | - | - | - | - |
| George Lloyd George Lloyd | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| George Lloyd George Lloyd | 2019 | $2,182,500 | $2,182,500 | - | $2,182,500 |
| James Reddoch, Ph.D. James Reddoch, Ph.D. | 2020 | $3,395,000 | $3,395,000 | - | $3,395,000 |
| James Reddoch, Ph.D. James Reddoch, Ph.D. | 2019 | $2,082,500 | $2,082,500 | - | $2,082,500 |
| No matching records found | |||||
Source: https://www.sec.gov/Archives/edgar/data/1802768/000114036121014879/nc10022939x1_def14a.htm
What are Royalty Pharma Plc's Past Insider Trades?
Royalty Pharma Plc's most recent insider trade came on August 11, 2023 by Terrance P Coyne who sold 75,000 units worth $2.31M . In the last 7 years, insiders at Royalty Pharma Plc have sold an estimated value of $809.94M and bought an estimated value of $165.99M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are George W Lloyd, EVP, Rory B Riggs, Director, and Henry A Fernandez, Director .
REPROS THERAPEUTICS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||